Who owns the REVYVE trademark?

The REVYVE trademark is owned by Kane Biotech Inc..

What class is the REVYVE trademark registered in?

The REVYVE trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for REVYVE?

The USPTO serial number for REVYVE is 98106841.

What is the registration number for REVYVE?

REVYVE is registered under USPTO registration number 7755802.

Sealvo

Home Search: REVYVEREVYVE #98106841

Back

Updated Oct 17, 2026·26 searches this week

View on USPTO TSDR Find similar marks

REV

USPTO Trademark Record

REGISTERED

REVYVE

SN 98106841·Reg 7755802·Filed Jul 28, 2023

Owner Kane Biotech Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

REVYVE (Serial No. 98106841), Registration No. 7755802, is a registered US trademark filed on Jul 28, 2023 by Kane Biotech Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: April 08, 2031

Mark Intelligence

REVYVE (Reg. #7755802) is a registered US trademark that has been protecting its owner, Kane Biotech Inc., since 2023. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Jul 28, 2023

SERIAL

98106841

REG#

7755802

REGISTERED

Apr 08, 2025

Filing Information

StatusREGISTERED

Filing DateJul 28, 2023

Serial Number98106841

Registration No.7755802

Registration DateApr 08, 2025

Status DateApr 08, 2025

Published for OppositionJun 18, 2024

Filing Basis & Declarations

Standard Characters ClaimedUse Application CurrentlyTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Jul 31, 2024

First use in commerce: Jul 31, 2024

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

22 events

REGISTERED-PRINCIPAL REGISTER

Apr 08, 2025

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Apr 08, 2025

NOTICE OF REGISTRATION CONFIRMATION EMAILED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Mar 18, 2025

CASE ASSIGNED TO INTENT TO USE PARALEGAL

STATEMENT OF USE PROCESSING COMPLETE

Mar 18, 2025

STATEMENT OF USE PROCESSING COMPLETE

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Mar 18, 2025

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Mar 18, 2025

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

TEAS STATEMENT OF USE RECEIVED

Jan 15, 2025

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Jan 15, 2025

USE AMENDMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Aug 13, 2024

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Jun 18, 2024

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jun 18, 2024

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

May 29, 2024

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

May 16, 2024

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

May 07, 2024

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

May 07, 2024

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

May 07, 2024

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

Apr 24, 2024

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Apr 24, 2024

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Apr 24, 2024

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Mar 29, 2024

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Aug 28, 2023

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Aug 01, 2023

NEW APPLICATION ENTERED

Other Marks by Kane Biotech Inc.

Additional USPTO filings from the same owner.

DER

DERMAKB

90566224

Kane Biotech Inc.

REGISTERED

DER

DERMAKB BIOFILM

90566243

Kane Biotech Inc.

REGISTERED

COA

COACTIV+

86823585

KANE BIOTECH INC.

REGISTERED

DIS

DISPERSINB

77134244

Kane Biotech Inc.

REGISTERED

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Recently filed and registered marks in the same international class.

REV

REVYVE

88128101

RXMM Health Ltd.

ABANDONED

Other Marks by C. Brandon Browning

Additional USPTO filings handled by the same attorney of record.

SUM

SUMMER CLASSICS

97670398

REGISTERED

SUM

SUMMER CLASSICS

97670414

REGISTERED

LOG

LogoMark

97679794

REGISTERED

FTX

97981633

REGISTERED

REVYVE

Run a conflict check

Other Marks by Kane Biotech Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by C. Brandon Browning

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company